Advertisement

Topics

Eisai to present abstracts from phase 3 REFLECT trial of Lenvima in unresectable HCC at 2019 Gastrointestinal Cancers Symposium

11:37 EST 15 Jan 2019 | PharmaBiz

Eisai Inc. to present four abstracts at the 2019 Gastrointestinal Cancers Symposium, taking place in San Francisco from January 17─19, 2019. The presentations feature the latest data from post─hoc analyses of the pivotal

Original Article: Eisai to present abstracts from phase 3 REFLECT trial of Lenvima in unresectable HCC at 2019 Gastrointestinal Cancers Symposium

NEXT ARTICLE

More From BioPortfolio on "Eisai to present abstracts from phase 3 REFLECT trial of Lenvima in unresectable HCC at 2019 Gastrointestinal Cancers Symposium"

Advertisement
Quick Search
Advertisement
Advertisement